Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
Top Cited Papers
Open Access
- 1 December 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. 7, 49-60
- https://doi.org/10.2147/ijn.s26766
Abstract
Peer reviewed article authored by (Chang HI, Yeh MK). Read article or submit your manuscript for publishing.Keywords
This publication has 75 references indexed in Scilit:
- Nanotechnology and human health: risks and benefitsJournal of Applied Toxicology, 2010
- Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomesSaudi Pharmaceutical Journal, 2010
- Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulationsVaccine, 2009
- Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancerBritish Journal of Cancer, 2006
- A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancerCancer Chemotherapy and Pharmacology, 2006
- Transfer of lipophilic drugs between liposomal membranes and biological interfaces: Consequences for drug deliveryEuropean Journal of Pharmaceutical Sciences, 2005
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology, 2004
- Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.2001
- Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.1999
- Characteristics of Lipid-Based Formulations That Influence Their Biological Behavior in the Plasma of PatientsClinical Infectious Diseases, 1996